ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-β/Smad signaling pathway to inhibit pathological HSC activation

Liu, Qi; Lv, Chengqian; Jiang, Yanan; Luo, Kunpeng; Gao, Yang; Liu, Jingyang; Zhang, Xu; Omar, Jan Mohammad; Jin, Shizhu*哈尔滨医科大学
PEErJ2022-2-15DOI: 10.7717/peerj.12872
3被引10阅读
引用收藏
分享

摘要

Liver cirrhosis (LC) involves multiple systems throughout the body, and patients with LC often die of multiple organ failure. However, few drugs are useful to treat LC. Hair follicle mesenchymal stem cells (HF-MSCs) are derived from the dermal papilla and the bulge area of hair follicles and are pluripotent stem cells in the mesoderm with broad prospects in regenerative medicine. As an emerging seed cell type widely used in skin wound healing and plastic surgery, HF-MSCs show considerable prospects in the treatment of LC due to their proliferation and multidirectional differentiation capabilities. We established an LC model in C57BL/6J mice by administering carbon tetrachloride (CCl4) and injected HF-MSCs through the tail vein to explore the therapeutic effects and potential mechanisms of HF-MSCs on LC. Here, we found that HF-MSCs improved liver function and ameliorated the liver pathology of LC. Notably, PKH67-labeled HF-MSCs were detected in the injured liver and expressed the hepatocyte-specific markers cytokeratin 18 (CK18) and albumin (ALB). In addition, in contrast to that in the LC group, the a-SMA expression showed a decreasing trend in the treatment group in vitro and in vivo, indicating that the pathological activation of hepatic stellate cells (HSCs) was inhibited by HF-MSC treatment. Moreover, the levels of transforming growth factor 13 (TGF-131) and p-Smad3, a signaling molecule downstream of TGF-131, were increased in mice with LC, while HF-MSC treatment reversed these changes in vivo and in vitro. Based on these findings, HF-MSCs may reverse LC by blocking the TGF-13/Smad pathway and inhibiting the pathological activation of HSCs, which may provide evidence for the application of HF-MSCs to treat LC.

学科与关键词

关键词
Liver cirrhosisHair follicle mesenchymal stem cellsHomingDifferentiationHepatic stellate cellsTGF-betaSmad signaling pathway
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
PEErJ
发表日期
2022-02-15
卷期
第 10 卷
页码
e12872
DOI
10.7717/peerj.12872
语言
ENGLISH
期刊等级
3区
成果收录
SCIE
资助标注
Xinjiang Production and Construction Corps [2020AB020]

作者

  • L

    Liu, Qi (第一作者)

    2 · harbin med univ

  • L

    Lv, Chengqian

    2 · harbin med univ

查看全部 9 位作者收起作者
  • J

    Jiang, Yanan

    harbin med univ

  • L

    Luo, Kunpeng

    2 · harbin med univ

  • G

    Gao, Yang

    2 · harbin med univ

  • L

    Liu, Jingyang

    2 · harbin med univ

  • Z

    Zhang, Xu

    2 · harbin med univ

  • O

    Omar, Jan Mohammad

    2 · harbin med univ

  • J

    Jin, Shizhu (通讯)

    2 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417